RxDoctor Payments Data

Lawrence Goldstone

Urology · Atlanta, GANPI 1952405037

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,329 of the $5,281 with a category attached, or 63.0%. 20 manufacturers reported payments, led by Boston Scientific at 46.6% of the total. Reporting peaked in 2019 at $2,357 and has fallen 97.6% since, to $56 in 2022.

$5,281in general payments, 2019–2025

Across 80 payments — averaging $66.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Procept Biorobotics Corporation$1K
  • SRS Medical Systems, Inc.$287
  • Astellas Pharma US Inc$287
  • Neotract Inc.$167
  • Merck$145
  • plus $803 from 14 others

What the payments were for

  • Consulting fees$4859%
  • Travel & lodging$1,36626%
  • Food & beverage$3,32963%
  • Education$1012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,281 in reported general payments places this provider in the 55th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia →

Other urology in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →